Cargando…
CD140b and CD73 are markers for human induced pluripotent stem cell‐derived erythropoietin‐producing cells
Renal anemia in chronic kidney disease is treated with recombinant human erythropoietin (rhEPO). However, some patients with anemia do not respond well to rhEPO, emphasizing the need for a more biocompatible EPO. Differentiation protocols for hepatic lineages have been modified to enable production...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050240/ https://www.ncbi.nlm.nih.gov/pubmed/31977161 http://dx.doi.org/10.1002/2211-5463.12800 |